Souhaitez-vous accéder aux communiqués récents ?

Oxford Brain Diagnostics Advances Vision for Measuring Brain Health and Neurodegenerative Disease with Five New Studies at AAIC 2026

Dublin, July 08, 2026 (GLOBE NEWSWIRE) -- The "Western Blotting Market Report 2026" has been added to ResearchAndMarkets.com's offering. The western blotting market is experiencing substantial...

Biocartis and Discovery announce a strategic collaboration to deliver end-to-end precision oncology solutions to pharmaceutical and biotech customers.

Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "Sweden Flu Diagnostic and Treatment Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. ...

In Vitro Toxicity Testing Technologies Advance as Drug Developers Seek Faster, More Predictive Safety Screening.

TRUE-See to participate in Microsoft for Startups program, which empowers founders using Azure with AI by providing tools, credit support and global reach

Response Biomedical Expands Global Diagnostics Portfolio with the Launch of the RAMP Xpress

Annals of Internal Medicine publishes study showing potential benefits of Stockholm3 in identifying patients with aggressive prostate cancer.

Austin, TX, USA, June 19, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “ECG Patch and Holter Monitor Market Size, Trends and Insights By Product Type...

Diazyme receives FDA 510(k) clearance for its isoform‑independent Lipoprotein(a) Molarity Assay, improving standardized cardiovascular risk assessment.